Actavis PLC (NYSE:ACT)

285.19
Delayed Data
As of Apr 27
 -10.22 / -3.46%
Today’s Change
193.00
Today|||52-Week Range
317.72
+10.79%
Year-to-Date

Today’s Trading

Previous close295.41
Today’s open296.95
Day’s range284.88 - 296.98
Volume3,989,571
Average volume (3 months)3,313,141
Market cap$119.6B
Dividend yield--
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+25.60%
Earnings growth (next 5 years)+14.95%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.13+0.23%
GSKGlaxoSmithKline+0.26+0.56%
BMYBristol-Myers Squibb-0.64-0.97%
ABBVAbbVie-1.05-1.59%
Data as of 04/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)$3.97
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers